People who drink more coffee – even decaffeinated – are less likely to develop liver cancer, an analysis of data from 26 studies has found.
Increasing coffee consumption may help to stave off liver cancer, a new study has suggested. Researchers have found that people who drink more coffee are less likely to develop hepatocellular cancer (HCC), the most common form of primary liver cancer – and the effect was even found in decaffeinated coffee.
Experts from the University of Southampton and the University of Edinburgh examined data from 26 studies involving more than 2.25 million participants. Compared with people who drank no coffee, those who drank one cup a day had a 20% lower risk of developing HCC, according to the study, published in the journal BMJ Open. Those who consumed two cups a day had a 35% reduced risk and for those who drank five cups, the risk was halved. They found the protective effect for decaf was “smaller and less certain than for caffeinated coffee”.
The authors wrote: “It may be important for developing coffee as a lifestyle intervention in chronic liver disease, as decaffeinated coffee might be more acceptable to those who do not drink coffee or who limit their coffee consumption because of caffeine-related symptoms.”
Professor Peter Hayes, of the University of Edinburgh, added: “We have shown that coffee reduces cirrhosis and also liver cancer in a dose-dependent manner. Coffee has also been reported to reduce the risk of death from many other causes. Our research adds to the evidence that, in moderation, coffee can be a wonderful natural medicine.”
Source: The Guardian